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Abstract
Objective: To determine the frequency of anxiety and depression among chronic spontaneous urticaria
patients presenting at a tertiary care hospital.
Methods: The prospective, cross-sectional study was conducted at the Aga Khan University Hospital,
Karachi, from February to August 2015, and comprised patients diagnosed with chronic spontaneous
urticaria at the dermatology clinic. All the participants were assessed for anxiety and depression using
Aga Khan University-Anxiety Depression Scale. Data was collected in face-to-face interview using a
structured questionnaire. The association of the condition with different characteristics were calculated
after stratification for age, gender, occupation and monthly income. SPSS 19 was used for data analysis.
Results: Of the 146 study participants, 84(57.5%) were males and 62(42.5%) were females. The overall
mean age was 39±15.6 years. Of the total, 39(26.7%) had depression and anxiety. Depression and
anxiety were more frequent among patients with a positive family history of mental disorders (p=0.02).
Conclusion: Anxiety and depression were found to be considerably common among chronic
spontaneous urticaria patients, with patients having a positive family history for mental illnesses
particularly vulnerable.
Keywords: Chronic spontaneous urticaria, Depression, Anxiety, Pakistan. (JPMA 70: 511; 2020).
https://doi.org/10.5455/JPMA.297139

Introduction

some cases it can extend up to 50 years.1,6

Urticaria is one of the most common skin diseases
characterised by itchy wheals with or without angioedema
that usually persists for less than 24 hours.1 Clinical
symptoms are due to the binding of antigen-to-antigen
specific imuunoglobulin E (IgE) on mast cells and
basophils.2 Chronic spontaneous urticaria (CSU) is defined
as spontaneous) development without external physical
stimuli of wheals, angioedema, or both for duration of
more than 6 weeks.3

Depression and anxiety are the most common psychiatric
disorders associated with CSU. The prevalence of
depression and anxiety in CSU patients ranges from 13.5%
to 40% and 7% to 30% respectively.7-11 The overall mean
prevalence of anxiety and depressive disorders among
the general population of Pakistan is reported to be
33.6%. 12 Quality of life in patients with CSU is as
compromised as in many other chronic skin diseases, like
psoriasis, atopic eczema and leprosy, along with increased
risk of anxiety, depression and somatoform disorders.9,13,14
The presence of depression and anxiety in CSU
compromises the quality of life and can also lead to poor
compliance with treatment and could lead to decline in
patient's satisfaction with medical care, which results in
the worsening of the situation.

The cause cannot be found in 50-75% cases4 and up to
40% of such cases are associated with autoimmune
reaction.5 The prevalence of urticaria has been reported
in many studies between 0.5-1%, while lifetime prevalence
is around 15-20%.1-5 Peak incidence had been reported
between 20-40 years of age. Females are reported to suffer
CSU nearly twice compared to males.1 In 30-55% of CSU
cases, the duration is estimated to be 1-5 years, but in
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CSU is one of the most disabling conditions, but its effect
on patient's quality of life is often underestimated, with
few reports in literature and no previous study in the local
population. The current study was planned to evaluate
the prevalence of depression and anxiety in CSU.
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Patients and Methods
The prospective, cross-sectional study was conducted at
the Department of Dermatology, Aga Khan University
Hospital (AKUH), Karachi, from February to August, 2015.
AKUH is a leading tertiary care hospital with wellestablished and equipped Dermatology Department,
which receives complicated and referred patients from
within the hospital and also from other remote areas of
the country.
After approval was taken from the institutional ethics
review committee, the sample size was calculated by using
World Health Organisation (WHO) software. 13 The
frequency of depression and anxiety among CSU patients
was based on earlier studies and ranged 7-40%.9,14
Therefore, while taking the anticipated proportion of
depression and anxiety to 40%, the sample size was
worked out at 95% level of confidence and precision of
8%. Non-probability convenience sampling was used to
raise the sample. All adult diagnosed CSU patients aged
14-60 years regardless of gender willing to take part in

study were recruited. Patients with diagnosed psychiatric
illness or those who were taking any psychiatric
medication before CSU onset were excluded, and so were
those who were not willing to volunteer.
After getting informed consent, general assessment was
done using a structured questionnaire which included
sociodemographic characteristics. Depression and anxiety
were assessed by using the Aga Khan University Anxiety
and Depression Scale (AKUADS) which comprised 25 items;
13 psychological and 12 somatic. It is a validated tool in
Urdu language for the local community against a gold
standard of assessment.15 Total scores range 0-75, and
those scoring 19 or above are considered to be suffering
from anxiety and depression.15 It is a differential scale rank
ordered for severity, and obtains an estimate of the distress
caused by the attribute being assessed from the
respondent directly on a four-point scale varying from
'present all the time (almost daily)', 'most of the time (2 to
5 times in a week)', 'sometimes only (2 or less than 2 times
in a week)' and 'not present at all'. It decreases the chances

Table: Association of different characteristics of chronic spontaneous urticaria (CSU) patients with depression and anxiety (n =146).
Variables
 25 years
26-50 years
<51 years
Sex
Male
Female
Marital status
Single
Married
Widow
Educational status
Uneducated
Informal education
Primary education
Secondary education
Graduation or above
Monthly income (PKR)
25,000
26,000-50,000
>50,000
Occupation
Self employed
Private job
Government Job
House maker
Student
Jobless
History of Angioedema
Yes
No
Family history of mental disorder Yes
No
Urticaria duration
< 6 months
 6 months
Age

Frequency n (%)

Depression and anxiety n (%)

No depression and anxiety n (%)

p-value

37(25.3)
71(48.6)
38(26)
84 (57.5)
62 (42.5)
41 (28.1)
96 (65.8)
9 (6.2)
11 (7.5)
15 (10.3)
40 (27.4)
28 (7.5)
52 ( %)
38 (26)
35
75 ( %)
14 (9.6)
51 (34.9)
9 (6.2)
43 (29.5)
27 (18.5)
2 (1.4)
4 (2.7)
142(97.3)

9 (23.1)
16 (41)
14 (39.9)
26 (66.7)
13 (33.3)
9 (23.1)
28 (71.8)
2 (5.1)
2 (5.1)
6 (15.4)
13 (33.3)
5 (12.8)
13 (33.3)
13 (33.3)
7 (17.9)
19 (48.7)
5 (12.8)
14 (35.9)
2 (5.1)
12 (30.8)
5 (12.8)
1 (2.6)
2 (5.1)
37 (94.9)
4 (10.3)
35 (89.7)
35 (89.7)
4 (10.3)

28 (26.2)
55 (1.4)
24 (33.4)
58 (54.2)
49 (45.8)
32 (29.9)
68 (63.6)
7 (6.5)
9 (8.4)
9 (8.4)
27 (25.2)
23 (21.5)
39 (36.4)
25 (23.4)
28 (26.2)
54 (50.5)
9 (8.4)
37 (34.6)
7 (6.5)
31 (29)
22 (20.6)
1 (0.9)
2 (1.9)
105 (98.1)
2 (1.9)
105 (98.1)
98 (91.6)
49 (8.4)

0.25

133(91.1)
13 (8.9)

0.65

0.45

0.38

0.82

0.28
0.02
0.72

p<0.05 significant, PKR: Pak Rupee
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of inter-rater bias and makes establishing inter-rater
reliability relatively easy.15

Discussion

Results

The current study is one of the few studies conducted in
dermatology clinics to assess anxiety and depression in
the local context. The CSU can affect every age group16,17
but the combined frequency of depression and anxiety
estimated was slightly higher. Literature has been
reporting high prevalence of mental disorders, like anxiety
and depression, among the general population of
Pakistan.17 However, the reported prevalence of anxiety
and depression in the general population vary widely
because of difference in study populations and assessment
methods. CSU has been reported to affect the mental
health with a substantial increase in the burden of anxiety
and depression among this vulnerable population.

Of the 146 study participants, 84(57.5%) were males and
62(42.5%) were females. The overall mean age was 39±15.6
years, with 71(48.6%) between 26-50 years of age, and
37(25.3%) were 25 years or less. Majority of the participants
were married 96(65.8%); 52(35.6%) had education up to
graduation or above; 11(7.5%) were uneducated; 15(10.3%)
had primary education; 40(27.4%) had education up to
middle or matric levels; 51(34.9%) were employed in
theprivate sector; 43(29.4%) were household women; and
4(2.7%) had a positive histor y of angioedema.

A high prevalence of psychiatric disorders in CSU patients
had been reported in a previous study. It highlighted that
the quality of life (QOL) in dermatological patients is a
strong predictor for psychiatric comorbidity.18 Poon et al.
found QOL impairment in CSU patients higher than the
two common debilitating dermatoses, acne and vitligo,
known to affect patients' QOL significantly.19,20 Anxiety
and depression was seen regardless of the disease
duration. The study results are consistent with previous
studies.20

Depression and anxiety was found in 39(26.7%) patients.
There was no statistically significant differences between
demographic characteristics of CSU patients who had
depression and anxiety compared to CSU patients with
no depression or anxiety (p>0.05). However, a statistically
significant difference was observed in family history of
mental disorders or illness between CSU patients with
depression and anxiety and those with no depression and
anxiety (p=0.02).

The current study used the AKUADS to assess the anxiety
and depression score of the cases.15 This is a very simplified
Urdu proforma, which facilitated the assessment in the
current study and had a high positive predictive value
(PPV) of around 83%.15 This scale has also been utilised in
multiple other studies conducted in Pakistan and
India. 21,22,23,24 Thus, it can also be considered a useful
diagnostic and screening tool to assess psychiatric issues
in patients presenting with various dermatological
conditions. QOL questionnaires may be suitable in one
cultural setting and may not be effective in others,
therefore revalidation may be necessary in a new
environment.25,26 In dermatological patients, the degree
of psychiatric comorbidity varies in accordance with the
disease state, setting of a study itself and the scale used.22
The study findings highlighted the importance of timely
detection of psychiatric disorders by dermatologists in
patients presenting with CSU with the help of a good
screening instrument.

Data was analysed using SPSS 19. Mean and standard
deviation (SD) were calculated for continuous variables,
whereas frequencies and percentages were calculated for
categorical variables, such as gender, occupation, marital
status, level of education and household income. Patients
scoring 9 were labeled as having depression and anxiety.
The association of different characteristics were also
evaluated after stratification for age, gender, occupation
and monthly income, and then compared using chi square
or fisher exact test. P<0.05 was considered significant.

Among those who had depression and anxiety, 16(41.0%)
were aged 26-50 years, but the difference in frequency of
depression and anxiety between different age groups was
not statistically significant (p=0.25).
Among those who had depression and anxiety, 39(89.7%)
participants had a duration of illness <6 months, while
4(10.3%) reported a duration of 6 months or more. Also,
13(33.3%) of the depressed patients were from the lowincome group; 7(17.9%) belonged to the middle income
group; and 19 (48.7%) were from the high income group
(Table).
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The current study has several inherent limitations. First of
all, it was a cross-sectional study so temporality between
the components cannot be established. Secondly, the
study was conducted in a private and relatively expensive
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health facility and their characteristics might be different
from patients at public hospitals. Hence, the study cannot
provide actual prevalence or burden of depression and
anxiety in the general population suffering from CSU.
Thirdly, the study confined itself to CSU patients, and,
hence, correlation of depression and anxiety with other
types of urticaria cannot be determined.
Multi-center studies are recommended which would give
a better understanding of the relationship of risk factors
among CSU patients.
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Conclusion
Mental health is a neglected area in many parts of Pakistan.
The study highlighted positive family history of mental
disorders as a possible and important risk modifier for the
development of anxiety and depression among CSU
patients.
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